Single Dose Therapy of Zoledronic Acid for the Treatment of Transient Osteoporosis of Hip
Objective To shorten the natural course of transient osteoporosis of hip (TOH), which is a self-limiting idiopathic condition and requires 6–12 months for the resolution of symptoms, various therapies including treatment with bisphosphonates have been attempted. There exist fewer case reports evalua...
Main Authors: | Sanjay Agarwala, Mayank Vijayvargiya |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Academy of Rehabilitation Medicine
2019-06-01
|
Series: | Annals of Rehabilitation Medicine |
Subjects: | |
Online Access: | http://www.e-arm.org/upload/pdf/arm-2019-43-3-314.pdf |
Similar Items
-
Transient osteoporosis of the hip and subclinical hypothyroidism: an unusual dangerous duet? Case report and pathogenetic hypothesis
by: Marco Paoletta, et al.
Published: (2020-08-01) -
Microscopic Evaluation of the Effect of Oral Microbiota on the Development of Bisphosphonate-Related Osteonecrosis of the Jaws in Rats
by: Felipe M. Silveira, et al.
Published: (2017-01-01) -
BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDY
by: George Adrian Ciobanu, et al.
Published: (2022-08-01) -
Transient Osteoporosis of the Hip: A Case Report
by: Pande K, et al.
Published: (2017-03-01) -
Transient Osteoporosis of the Hip: A Case Report - Case Report
by: Cengiz Bahadır, et al.
Published: (2007-03-01)